Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $5.4 million.

  • Cellebrite DI's Change in Account Payables rose 3893.29% to $5.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $4.9 million, marking a year-over-year increase of 7941.92%. This contributed to the annual value of $4.9 million for FY2025, which is 7941.92% up from last year.
  • Latest data reveals that Cellebrite DI reported Change in Account Payables of $5.4 million as of Q4 2025, which was up 3893.29% from $713000.0 recorded in Q3 2025.
  • Cellebrite DI's Change in Account Payables' 5-year high stood at $5.4 million during Q4 2025, with a 5-year trough of -$5.4 million in Q2 2022.
  • Its 5-year average for Change in Account Payables is $503650.0, with a median of $190500.0 in 2023.
  • As far as peak fluctuations go, Cellebrite DI's Change in Account Payables tumbled by 220680.85% in 2022, and later surged by 112024.92% in 2024.
  • Quarter analysis of 5 years shows Cellebrite DI's Change in Account Payables stood at $3.0 million in 2021, then tumbled by 130.29% to -$895000.0 in 2022, then skyrocketed by 135.87% to $321000.0 in 2023, then surged by 1120.25% to $3.9 million in 2024, then surged by 38.93% to $5.4 million in 2025.
  • Its last three reported values are $5.4 million in Q4 2025, $713000.0 for Q3 2025, and -$166000.0 during Q2 2025.